FDA Developing New Risk and Benefit Perception Scale -
On April 21, 2014, continuing its scrutiny of the disclosures of risks and benefits in prescription drug advertising, FDA announced a plan to conduct a study...more
On January 17, FDA issued its opening sally in the new compounding pharmacy enforcement regime by issuing a Warning Letter to Avella of Deer Valley in Phoenix, AZ. The letter is based on a nearly year-old inspection (February...more
Following enactment of the Drug Quality and Security Act last month, FDA has quickly issued a new guidance for compounding pharmacies that choose to not register as "outsourcing facilities" and subject themselves to federal...more
In This Issue:
- Snapshot of the Agency: FDA-regulated products
- Recent Public Health Milestones
- Innovative Programs at FDA
..A. FDA has a number of programs intended to speed the availability of...more
12/17/2013
/ Affordable Care Act ,
Clinical Trials ,
Food and Drug Administration (FDA) ,
Food Safety ,
Generic Drugs ,
Healthcare ,
Healthcare Reform ,
Medical Devices ,
New Regulations ,
Prescription Drugs ,
Proposed Regulation ,
Veterinary Products
On Wednesday, December 4, FDA will publish six key documents in the implementation of the Compounding Quality Act, signed into law by President Obama on Monday, December 2. In addition, FDA has withdrawn its current guidance...more